Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021
Frontiers in Public Health · 10.07.2024 · 12
DOI: 10.3389/fpubh.2024.1402795 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Public Health, online erschienen am 10.07.2024. Verfasst von Mark A Fletcher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Vaccines Emerging Markets, Medical Affairs, Paris, France. Hauptthemen laut MEDLINE: Pneumococcal Infections, Serogroup, Streptococcus pneumoniae, Pneumococcal Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Background
Most publications on invasive pneumococcal disease (IPD) serotype distribution are from about 20 countries (Australia, Canada, China, European Union members, Japan, New Zealand, South Korea, and USA). Here, we reviewed the literature among underrepresented countries in the Americas (AMRO), Africa (AFRO), Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO) WHO regions.
Methods
We performed a systematic review of the most recent IPD serotype surveillance publications (from 01/01/2010 to 31/12/2021, Medline/Embase) in those WHO regions. Selection criteria were delineated by contemporality, within-country geographical scope, and number of samples. Reported serotype distributions for each country were stratified by age group, pneumococcal conjugate vaccine (PCV) serotype category (considering undifferentiated serotypes), and PCV program period (pre-PCV, intermediate, or PCVhv [higher valency PCV formulation]). Pre-PCV period pooled data estimated PCV serotype category distribution by age group across WHO regions, while for the PCVhv period, country-level dataset tables were prepared.
Results
Of 2,793 publications screened, 107 were included (58 pediatric, 11 adult, 37 all ages, and one comprising every age group). One-third of eligible countries (51/135) published serotype distribution, ranging from 30 to 43% by WHO region. Considering number of samples per WHO region, a few countries prevailed: AMRO (Brazil), AFRO (South Africa, Malawi, and Burkina Faso), and WPRO (Taiwan). In the pre-PCV period, PCV13 formulation serotypes predominated: ranging from 74 to 85% in children and 58–86% in adults in the different WHO regions. The PCVhv period represented half of the most recent IPD surveillance by countries (26/51). Undifferentiated serotypes represented >20% of IPD from most countries (34/51).
Conclusion
Ubiquity of undifferentiated serotypes among the publications could constrain estimates of PCV program impact and of serotype coverage for newer PCVhv formulations; consequently, we recommend that countries favor techniques that identify serotypes specifically and, rather than reporting PCV formulation serotype distributions, provide serotype results individually.
Systematic review registration
The protocol has been prospectively registered at PROSPERO, identifier: CRD42021278501. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=278501 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pfizer Vaccines Emerging Markets, Medical Affairs, Paris, France.
- Pfizer Vaccines Emerging Markets, Medical Affairs, New York, NY, United States.
- P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
Förderung
- Pfizer
Zitieren
APA
Fletcher, M. A., Daigle, D., Siapka, M., Baay, M., Hanquet, G., & Del Carmen Morales, G. (2024). Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1402795
Vancouver
Fletcher MA, Daigle D, Siapka M, Baay M, Hanquet G, Del Carmen Morales G. Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021. Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1402795
BibTeX
@article{Fletcher2024,
author = {Fletcher, Mark A and Daigle, Derek and Siapka, Mariana and Baay, Marc and Hanquet, Germaine and Del Carmen Morales, Graciela},
title = {Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021},
journal = {Frontiers in Public Health},
year = {2024},
volume = {12},
doi = {10.3389/fpubh.2024.1402795}
}
EUVIMED